Ls (P = 0.024), NK cells (P,0.001) and NK/T cells (P,0.001) increased over time but not those of ?naive CD4+ T cells (P = 0.13). Further, high numbers of transplanted CD3+ T cells were associated with higher CP21 site counts CD3+ T cells (P = 0.009), CD8+ T cells (P = 0.003), and CD4+ T cells (P = 0.0099), while high donor age was associated with lower counts of CD3+ T cells (P = 0.04), CD4+ T cells ?(P = 0.05), and naive CD4+ T cells (P = 0.021). There was no significant association between MSC administration and lymphocyte subset counts after transplantation.ml, demonstrating the persistence of recipient T 22948146 cells at the timeIL-7 Plasma LevelsMedian IL-7 plasma levels remained below 6 pg/L throughout the first 100 days (the upper limit of AKT inhibitor 2 normal range being 9.2 pg/ mL (Quantikine?HS catalog number HS750)), although IL-7 plasma levels were significantly higher on days 7 (5.1 pg/mL, P = 0.002), 14 (5.2 pg/mL, P,0.0001) and 28 (5.1 pg/mL, P = 0.03) (but not thereafter) than before transplantation (median value of 3.8 pg/mL) (Figure 1G). Using generalized linear mixed models, low number of transplanted CD3+ T cells (P = 0.001), low ALC level the day of IL-7 assessment (P,0.0001), high donor age (P = 0.003), having received PBSC from unrelated donors (p = 0.006), and high level of CRP the day of IL-7 assessment (P = 0.033) were associated with high levels of IL-7 (Table 2).Il-15 Serum LevelsMedian IL-15 serum levels were significantly higher on days 7 (12.5 pg/mL, P,0.001), 14 (10.5 pg/mL, P,0.001) and 28 (6.2 1662274 pg/mL, P,0.001) than before transplantation (median value of 2.4 pg/mL) 
(Figure 1H). IL-15 levels on day 7 and 14 were significantly higher in 4 Gy than 2 Gy TBI. Using generalized linear mixed models, conditioning with 4 versus 2 Gy TBI (P = 0.002), having received PBSC from unrelated donors (P = 0.001), low ALC level the day of IL-15 assessment (P,0.001), and high level of CRP the day of IL-15 assessmentIL-7 and IL-15 after Allo-HSCTIL-7 and IL-15 after Allo-HSCTFigure 1. Median ALC (A), median MNC-subset cell counts (B ), and median IL-7 (G) and IL-15 (H) after allogeneic hematopoietic cell transplantation following 2 Gy (continuous line) or 4 Gy (broken line) total body irradiation. The error bars shows the 25th and 75th percentiles. For ALC and MNC-subset, horizontal lines show the medians and the grey square the limit of normal value (if non truncated) in 47 healthy volunteer donors; for IL-7, horizontal line shows the medians and the grey square the limit of normal value according to the manufacturer brochure. *, P,0.05; **, P,0.01; ***, P,0.001. doi:10.1371/journal.pone.0055876.g(P = 0.006) were each associated with high IL-15 levels on days 7 and 14 after allo-HSCT (Table 2).Correlation between IL-7 and IL-15 Levels and Lymphocyte Subset Counts on Days 14 or 28 after alloHSCTDay 14 IL-7 levels inversely correlated with day 14 counts of CD3+ T cells (R = 20.46, P = 0.002; Figure 2A), CD8+ T cells (R = 20.41, P = 0.006), CD4+ T cells (R = 20.44, P = 0.004), and memory CD4+ T cells (R = 20.45, P = 0.003), but not with counts ?of naive CD4+ T cells (R = 20.28, P = 0.07), NK/T cells (R = 20.04, P = 0.8) nor NK cells (R = 20.14, P = 0.4). There was a weak association between day 14 IL-7 and IL-15 levels (R = 0.27, P = 0.049). Further, day 14 IL-15 levels correlated with day 14 counts of NK cells (R = 20.32, P = 0.039; Figure 2B) and of NK/T cells (R = 20.32, P = 0.037), but not with those of other T cell subsets. Day 28 IL-7 levels inversely.Ls (P = 0.024), NK cells (P,0.001) and NK/T cells (P,0.001) increased over time but not those of ?naive CD4+ T cells (P = 0.13). Further, high numbers of transplanted CD3+ T cells were associated with higher counts CD3+ T cells (P = 0.009), CD8+ T cells (P = 0.003), and CD4+ T cells (P = 0.0099), while high donor age was associated with lower counts of CD3+ T cells (P = 0.04), CD4+ T cells ?(P = 0.05), and naive CD4+ T cells (P = 0.021). There was no significant association between MSC administration and lymphocyte subset counts after transplantation.ml, demonstrating the persistence of recipient T 22948146 cells at the timeIL-7 Plasma LevelsMedian IL-7 plasma levels remained below 6 pg/L throughout the first 100 days (the upper limit of normal range being 9.2 pg/ mL (Quantikine?HS catalog number HS750)), although IL-7 plasma levels were significantly higher on days 7 (5.1 pg/mL, P = 0.002), 14 (5.2 pg/mL, P,0.0001) and 28 (5.1 pg/mL, P = 0.03) (but not thereafter) than before transplantation (median value of 3.8 pg/mL) (Figure 1G). Using generalized linear mixed models, low number of transplanted CD3+ T cells (P = 0.001), low ALC level the day of IL-7 assessment (P,0.0001), high donor age (P = 0.003), having received PBSC from unrelated donors (p = 0.006), and high level of CRP the day of IL-7 assessment (P = 0.033) were associated with high levels of IL-7 (Table 2).Il-15 Serum LevelsMedian IL-15 serum levels were significantly higher on days 7 (12.5 pg/mL, P,0.001), 14 (10.5 pg/mL, P,0.001) and 28 (6.2 1662274 pg/mL, P,0.001) than before transplantation (median value of 2.4 pg/mL) (Figure 1H). IL-15 levels on day 7 and 14 were significantly higher in 4 Gy than 2 Gy TBI. Using generalized linear mixed models, conditioning with 4 versus 2 Gy TBI (P = 0.002), having received PBSC from unrelated donors (P = 0.001), low ALC level the day of IL-15 assessment (P,0.001), and high level of CRP the day of IL-15 assessmentIL-7 and IL-15 after Allo-HSCTIL-7 and IL-15 after Allo-HSCTFigure 1. Median ALC (A), median MNC-subset cell counts (B ), and median IL-7 (G) and IL-15 (H) after allogeneic hematopoietic cell transplantation following 2 Gy (continuous line) or 4 Gy (broken line) total body irradiation. The error bars shows the 25th and 75th percentiles. For ALC and MNC-subset, horizontal lines show the medians and the grey square the limit of normal value (if non truncated) in 47 healthy volunteer donors; for IL-7, horizontal line shows the medians and the grey square the limit of normal value 
according to the manufacturer brochure. *, P,0.05; **, P,0.01; ***, P,0.001. doi:10.1371/journal.pone.0055876.g(P = 0.006) were each associated with high IL-15 levels on days 7 and 14 after allo-HSCT (Table 2).Correlation between IL-7 and IL-15 Levels and Lymphocyte Subset Counts on Days 14 or 28 after alloHSCTDay 14 IL-7 levels inversely correlated with day 14 counts of CD3+ T cells (R = 20.46, P = 0.002; Figure 2A), CD8+ T cells (R = 20.41, P = 0.006), CD4+ T cells (R = 20.44, P = 0.004), and memory CD4+ T cells (R = 20.45, P = 0.003), but not with counts ?of naive CD4+ T cells (R = 20.28, P = 0.07), NK/T cells (R = 20.04, P = 0.8) nor NK cells (R = 20.14, P = 0.4). There was a weak association between day 14 IL-7 and IL-15 levels (R = 0.27, P = 0.049). Further, day 14 IL-15 levels correlated with day 14 counts of NK cells (R = 20.32, P = 0.039; Figure 2B) and of NK/T cells (R = 20.32, P = 0.037), but not with those of other T cell subsets. Day 28 IL-7 levels inversely.
